Phase III fliGHt trial provides new safety data on TransCon Growth Hormone in pediatric patients May 21, 2019
Tolimidone leads to significant reduction of HbA1c in phase IIb trial in type 2 diabetes May 15, 2019
Confirmatory phase III trial of dasiglucagon in severe hypoglycemia meets primary endpoint May 14, 2019
Avotres opens enrollment in phase I/II trial of dendritic cell therapy AVT-001 for type 1 diabetes May 13, 2019
RSS